Abbott Laboratories (ABT) : The money flow is calculated as the dollar value of composite uptick trades minus the dollar value of downtick trades, which was negative (2.59 million) in Abbott Laboratories (ABT). On Wednesday, The value of composite uptick trades was $2.42 million, whereas, the value of composite downtick trades was $5 million and the ratio between the two was 0.48, indicating selling on strength. Traders involved in block trades booked profits in their holdings as seen in the transactions on downticks valued at $2.72 million. The negative money flow of ($2.72 million) shows selling on strength. Abbott Laboratories (ABT) gained $0.02 intraday at $42.35 and registrered 0.04% for the week.
Shares of Abbott Laboratories appreciated by 0.88% during the last five trading days but lost 2.22% on a 4-week basis. Abbott Laboratories is up 10.32% in the last 3-month period. Year-to-Date the stock performance stands at -4.07%.
Abbott Laboratories (ABT) : 15 analysts are covering Abbott Laboratories (ABT) and their average rating on the stock is 1.6, which is read as a Buy. 10 equity analysts believe that the stock has a bright future and the price doesnt capture all of its upside, hence they rate the stock as a Strong Buy. Abbott Laboratories (ABT) also receives 1 more Buy recommendations from analysts who believe that the stock will do well going forward. A Zacks Investment Research rank of 2, which recommends a Buy affirms that they expect a large upside in the stock from the current levels. A total of 4 brokerage firms believe that the stock is fairly valued, hence they advise a Hold on the stock.
Abbott Laboratories (NYSE:ABT): stock was range-bound between the intraday low of $41.91 and the intraday high of $42.53 after having opened at $42.25 on Wednesdays session. The stock finally closed in the red at $42.25, a loss of -0.09%. The stock remained in the red for the whole trading day. The total traded volume was 5,228,267 shares. The stock failed to cross $42.53 in Wednesdays trading. The stocks closing price on Thursday was $42.33.
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture and sale of a range of health care products. Abbott operates in four business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. The Established Pharmaceutical Products segment includes the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment includes the sales of a line of adult and pediatric nutritional products. The Nutritional Products includes the sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. The Vascular Products includes the sales of coronary, endovascular, structural heart, vessel closure and other medical device products.